Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
3
Number of overlapping holdings
7.9%
% of IBRN's 52 holdings also in PSIL
33.3%
% of PSIL's 28 holdings also in IBRN
Overlap by Weight
Sector Drift (IBRN minus PSIL)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBRN |
Weight in PSIL |
Overlap | |
|---|---|---|---|---|
 |
NEUROCRINE BIOSCIENCES INC | 4.7% | 4.6% | 4.6% |
|
INTRA-CELLULAR THERAPIES INC | 4.8% | 4.5% | 4.5% |
 |
ALKERMES PLC | 3.8% | 6.3% | 3.8% |
Position Highlights (Non-Overlapping Exposures)
IBRN Overweight Relative to PSIL
 |
SK BIOPHARMACEUTICALS CO., LTD. | 4.6% |
 |
ARGENX SE ADR | 4.5% |
|
SUPERNUS PHARMACEUTICALS INC | 4.3% |
|
ACADIA PHARMACEUTICALS INC | 4.2% |
|
CATALYST PHARMACEUTICAL PART | 4.2% |
|
SAREPTA THERAPEUTICS INC | 4.1% |
|
BIOGEN IDEC INC | 4.0% |
|
SCHOLAR ROCK HOLDING CORP. | 3.9% |
|
PTC THERAPEUTICS INC | 3.9% |
|
INTEGRA LIFESCIENCES HOLDING | 3.3% |
IBRN Underweight Relative to PSIL
 |
ATAI LIFE SCIENCES N.V. | -6.4% |
|
INCANNEX HEALTHCARE INC. | -5.2% |
|
SAGE THERAPEUTICS INC | -4.3% |
|
ALKERMES PLC | -2.5% |
|
RELMADA THERAPEUTICS INC | -1.3% |
 |
NUMINUS WELLNESS INC | -1.2% |
|
NEURONETICS, INC. | -0.3% |
|
NEUROCRINE BIOSCIENCES INC | 0.1% |
 |
IDORSIA LTD. | 0.2% |
|
ELIEM THERAPEUTICS, INC. | 0.2% |